145 related articles for article (PubMed ID: 32908786)
1. LncRNA DLG1-AS1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Downregulating miR-203.
Li S
J Breast Cancer; 2020 Aug; 23(4):343-354. PubMed ID: 32908786
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer.
Wei M; Liu L; Wang Z
Oncol Lett; 2019 Dec; 18(6):6775-6780. PubMed ID: 31788122
[TBL] [Abstract][Full Text] [Related]
3. MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer.
Zhao X; Fu L; Zhai L; Yang X; Gao R
J Biochem Mol Toxicol; 2023 Mar; 37(3):e23247. PubMed ID: 36654514
[TBL] [Abstract][Full Text] [Related]
4. PBX3-activated DLG1-AS1 can promote the proliferation, invasion, and migration of TNBC cells by sponging miR-16-5p.
Zhang H; Shi X; Ge Z; Wang Z; Gao Y; Gao G; Xu W; Qu X
Mol Ther Oncolytics; 2022 Jun; 25():201-210. PubMed ID: 35592389
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA
Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F
J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21.
Gao J; Wang S; Zhang Z; Li J
BMC Cancer; 2021 Jun; 21(1):745. PubMed ID: 34182945
[TBL] [Abstract][Full Text] [Related]
7. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
[TBL] [Abstract][Full Text] [Related]
9. lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF.
Zou MJ; Cheng XR; Liu RF
J Obstet Gynaecol Res; 2022 Jul; 48(7):1836-1847. PubMed ID: 35388952
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
Jiang B; Liu Q; Gai J; Guan J; Li Q
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
[TBL] [Abstract][Full Text] [Related]
11. lncRNA DLG1-AS1 Promotes Cell Proliferation by Competitively Binding with miR-107 and Up-Regulating ZHX1 Expression in Cervical Cancer.
Rui X; Xu Y; Huang Y; Ji L; Jiang X
Cell Physiol Biochem; 2018; 49(5):1792-1803. PubMed ID: 30231238
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
14. LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis.
Li P; Zeng Y; Chen Y; Huang P; Chen X; Zheng W
Cancer Cell Int; 2022 Mar; 22(1):116. PubMed ID: 35279146
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
[TBL] [Abstract][Full Text] [Related]
16. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
[TBL] [Abstract][Full Text] [Related]
17. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells.
Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438
[TBL] [Abstract][Full Text] [Related]
19. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y
Front Oncol; 2021; 11():678474. PubMed ID: 34026654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]